Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Do Clinical Severity Scores Correlate With the Quality of Life in Children With Psoriasis? a Cross-Sectional Study of Iranian Pediatric Patients Publisher Pubmed



Nourmohammadpour P1, 2 ; Ehsani AH1, 2 ; Hatami P1 ; Fakoor Y1 ; Fahim S1, 2 ; Mohsenolhosseini Z1 ; Aryanian Z1, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Dermatology, School of Medicine Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Dermatology, Babol University of Medical Sciences, Babol, Iran

Source: Pediatric Dermatology Published:2022


Abstract

Background: Psoriasis is a common chronic dermatosis that can negatively affect patients' lives. Aim: To obtain more insight about how having psoriasis and how the various clinical and physical characteristics of the disease impact the health-related quality of life (HRQoL) of pediatric patients. Methods: A retrospective cross-sectional study was designed with 40 pediatric patients with psoriasis. HRQoL was evaluated using the Children Dermatology Life Quality Index (CDLQI). Results: A total of 40 patients enrolled in this study. The mean age of participants was 12.42 ± 7.1 years (age range: 4–16 years), 21 males (52.5%), and 19 females (47.5%). The mean Psoriasis Area Severity Index (PASI) score was 8.03 ± 9.31 with a range of 0.4–25. Mean CDLQI score was 18.87 ± 8.15, indicating a considerable burden on health-related QoL. There was a strong positive correlation between CDLQI and PASI scores (p <.001, r:.653). Conclusion: The negative effect of psoriasis on HRQoL in pediatrics was confirmed, and a strong correlation between disease severity scores and HRQoL in children with psoriasis was found in this study. Taking HRQoL indices into account while managing adolescent patients will improve our insight into the patient's experience and may provide better patient adherence to treatment. © 2022 Wiley Periodicals LLC.
Related Docs
1. Multiple Cycles of Rituximab Therapy for Pemphigus: A Group of Patients With Difficult- To-Treat Disease or a Consequence of Late Rituximab Initiation?, Dermatologic Therapy (2022)
2. Covid Vaccination in Patients Under Treatment With Rituximab: A Presentation of Two Cases From Iran and a Review of the Current Knowledge With a Specific Focus on Pemphigus, Dermatologic Therapy (2022)
3. Serious Health Threat of Mucormycosis During the Ongoing Covid-19 Pandemic: What Dermatologists Need to Know in This Regard, International Journal of Dermatology (2022)
4. Striae Gravidarum Treatment: Evaluating Non-Ablating Fractional Laser (Nafl) Efficacy and Safety, Journal of Cosmetic and Laser Therapy (2023)
5. Punctate Pattern and Pemphigus: Is There Any Evidence of Punctate Pattern Among Iranian Patients?, American Journal of Dermatopathology (2022)
6. A Prospective Comparative Study of Two Regimens of Diphenylcyclopropenone (Dpcp) in the Treatment of Alopecia Areata, International Immunopharmacology (2021)
7. Metabolic Derangement in Patients With Vitiligo: A Cross-Sectional Study, Journal of Investigative Medicine (2022)
Experts (# of related papers)
View all Related Experts
Zeinab Aryanian (6)
Kamran Balighi (3)